Home >
Medicine Info >
Oxylin 0.25 mg Eye Drops
Loading interface...

Oxylin 0.25 mg Eye Drops

Manufactured byAllergan India Ltd.
ContainsOxymetazoline
Description
Oxylin 0.25 mg Eye Drops is an ophthalmic agent which is used to reduce the swelling of the blood vessels in the eyes, thereby temporarily reducing their redness
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Oxylin 0.25 mg Eye Drops

  • Blurred vision
  • Eye irritation

Uses of Oxylin 0.25 mg Eye Drops

What is it prescribed for?

  • Redness of eye
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Allergy

This medicine is not recommended for use if you have a known allergy to Oxymetazoline or any other inactive ingredients present with the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
General warnings

Use in children

This medicine is not recommended for use in patients less than 6 years of age unless specifically directed by the doctor.

Driving or operating machinery

The use of this medicine may cause blurred vision in some patients. If you experience blurred vision during treatment with this medicine, it is advised that you do not perform any activities such as driving a vehicle or operating machinery until your vision is clear.

Missed Dose

Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Ergot alkaloids

Monoamine oxidase inhibitors

Beta-2 adrenergic bronchodilators

Disease interactions

Diabetes

This medicine should be administered with caution in patients having diabetes due to the increased risk of elevated blood glucose levels, especially when used for a prolonged period of time or more than prescribed. You may require a dose adjustment and more frequent monitoring of blood sugar levels while using this medicine. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Benign prostatic hyperplasia

This medicine should be used with caution in patients suffering from benign prostatic hyperplasia due to the increased risk of difficulty with urination. This risk is especially higher if the medicine is used for a prolonged period of time or more than prescribed. Report any unusual symptoms to the doctor immediately. You may require a dose adjustment and more frequent clinical monitoring while using this medicine. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition of the patient.

Cardiovascular disorders

This medicine should be administered with caution in patients with cardiovascular diseases due to the increased risk of worsening of the patient's condition, especially when used for a prolonged period of time or more than prescribed. You may require a dose adjustment and more frequent monitoring of heart function while using this medicine. Replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Glaucoma

This medicine should be administered with extreme caution in patients with glaucoma due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Administer this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine acts by reducing the swelling of the blood vessels in the eyes. This helps in decreasing the discomfort and redness caused by the dilated blood vessels.
Legal Status

Approved

Approved

Approved

Unknown

Classification

Category

Alpha adrenergic agonists, Ophthalmic antihistamines and decongestants

Schedule

OTC

Oxymetazoline - DrugBank [Internet]. Drugbank.ca. 2017 [cited 24 July 2017]. Available from:

https://www.drugbank.ca/drugs/DB00935
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 18 Oct 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.